ASAC trial reveals aspirin fails to improve metastatic colorectal cancer survival
Colorectal cancer is one of the most common cancers worldwide, and up to half of patients develop liver metastases during the course of their disease.
Read original article on The Medical News →Related news
-
Medetomidine: The dangerous animal sedative turning up in Scotland's street drugs
United Kingdom
-
Candy-coated Lollylab checks saliva for medication
United Kingdom
-
Genetic links to ADHD, autism and depression changed with age
United Kingdom
-
Nonprofit Brings Free Music Education to More Than 20,000 Miami Students in 131 Schools
United Kingdom
-
Counting to 5 reveals how children's 'inner speech' develops
United Kingdom
-
Experts warn of dangers in consuming raw milk and dairy products
United Kingdom
-
Youth e-bike and e-scooter injuries rise nearly four-fold, study finds
United Kingdom
-
Doctors faced an AI-use penalty after disclosing AI use to patients
United Kingdom